Bladder seen under White Light

Bladder seen under Blue Light

Confidence for Bladder Cancer Patients Making cancer visible
This video shows a bladder cancer surgery procedure (Transurethral Resection of Bladder Tumor (TURBT) performed with Blue Light as adjunct to White Light Cystoscopy. With courtesy of Maximillian Burger, Germany
Latest News See more news
  • 16.05.2019
    Reduced recurrence by standardizing the first TURBT

    Data from a prospective intervention study in non-muscle-invasive bladder cancer (NMIBC) patients show that a systematic, guideline-based approach to the first TURBT improve patient outcomes.

  • 14.05.2019
    Photocure ASA: Results for the first quarter of 2019

    Oslo, Norway, 14 May 2019: Photocure ASA (OSE:PHO), today reported a revenue growth of 52% in local currency for the U.S. market in the first quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 51.2 million (Q1 2018: NOK 40.7) and a recurring EBITDA of NOK -1.5 million (NOK -4.0 million). The company continues to receive strong endorsement for the use of Blue Light Cystoscopy (BLC) with Cysview and reiterates the significant revenue growth and profit opportunities in the U.S. market.

  • 09.05.2019
    Photocure ASA – Annual general meeting held

    Oslo, Norway, 9 May 2019: Photocure ASA (OSE: PHO), held its annual general meeting on 9 May 2019 at 17:00 hours (CET).

Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients